Genetics of monogenic autoinflammatory diseases: past successes, future challenges.
Ivona Aksentijevich, Daniel L Kastner
https://pubmed.ncbi.nlm.nih.gov/21727933/Actively Recruiting
Led by National Human Genome Research Institute (NHGRI) · Updated on 2026-10-13
5000
Participants Needed
5
Research Sites
N/A
Total Duration
Researchers are exploring the genetics and underlying causes of diseases that cause intermittent fever, such as familial Mediterranean fever, TRAPS, hyper-IgD syndrome, and related disorders. This observational study includes patients with these conditions, their family members, and healthy volunteers aged 7 years and older. The goal is to identify genetic variants and immune features linked to these inflammatory diseases and better understand their clinical characteristics. Participants provide medical history, undergo physical exams, and give blood and urine samples for genetic and immunologic studies. Tests may include X-rays, specialist consultations, skin biopsies, leukapheresis, and bone marrow procedures. Patients and relatives with these diseases receive regular follow-up every six months to monitor symptoms and adjust treatment, while healthy volunteers have brief health checks and blood samples collected. Throughout the study, researchers collect genetic material and monitor immune cells, inflammatory markers, and gene expression. Participants may be asked to provide additional blood samples during specific periods. Genetic counseling is provided to discuss risks and treatment options. The study tracks genetic links annually and may include retrospective analysis of medical data, with participation involving ongoing assessments over time.
CONDITIONS
Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics
A
Amanda K Ombrello, M.D.
B
Benjamin D Solomon, M.D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
National Human Genome Research Institute (NHGRI)
Lead Sponsor
University of Massachusetts, Worcester
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote)
Duration - Variable based on participant
Participants provide medical and family history, physical exams, blood and urine samples, and may undergo X-rays or specialist consultations. Genetic and immune studies are performed using these samples.
1 or more visits as needed
Duration - Ongoing as determined by study
Patients and affected relatives have follow-up visits approximately every 6 months to monitor symptoms, adjust treatments, and provide additional blood and urine tests. Healthy volunteers may have fewer assessments.
Visits approximately every 6 months
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Ivona Aksentijevich, Daniel L Kastner
https://pubmed.ncbi.nlm.nih.gov/21727933/Ariel C Bulua, Douglas B Mogul, Ivona Aksentijevich...
https://pubmed.ncbi.nlm.nih.gov/22006113/Philip J Hashkes, Steven J Spalding, Edward H Giannini...
https://pubmed.ncbi.nlm.nih.gov/23070486/National Human Genome Research Institute (NHGRI)
Lead Sponsor
University of Massachusetts, Worcester
Collaborating Sponsor